speaker_name stringlengths 0 148 | speaker_role stringclasses 7
values | speaker_party stringclasses 9
values | intervention_language stringclasses 22
values | original_language stringclasses 27
values | date timestamp[ms]date 2009-07-14 00:00:00 2023-09-14 00:00:00 | year stringdate 2009-01-01 00:00:00 2023-01-01 00:00:00 | debate_title stringlengths 5 666 | text stringlengths 7 50.5k | translated_text stringlengths 9 36.6k ⌀ |
|---|---|---|---|---|---|---|---|---|---|
Aldo Patriciello | MEP | PPE | en | it | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | I would like to thank Mr Watson for his excellent work. I voted in favour because I agree it is essential for Moldova to proceed with the implementation of the ENP Action Plan and of the reforms it has set out in the document ‘Rethink Moldova’. Holding of elections, as required by the constitution, is essential for th... | null |
Mario Pirillo | MEP | S&D | en | it | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | The adoption of the protocol on the general principles for the participation of the Republic of Moldova in European Union programmes is fundamentally important for continuing down the road of a more structured collaboration, which should reasonably conclude in future with an association agreement. The current constitu... | null |
Rovana Plumb | MEP | S&D | en | ro | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | As part of the European Neighbourhood Policy, the initiative of gradually opening up certain EU programmes and agencies to participation from ENP partner countries is one of the numerous measures intended to promote reform, modernisation and transition in the countries neighbouring the European Union. The decision was... | null |
Paulo Rangel | MEP | PPE | en | pt | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | I voted in favour of the signing of this Protocol to the Partnership and Cooperation Agreement between the EU and Moldova because I understand that the assistance that the EU has provided to Moldova is essential for that country to be able to implement necessary reforms and to achieve the desired political stability, ... | null |
Raül Romeva i Rueda | MEP | Greens/EFA | en | en | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | This report refers to the draft Council decision on the conclusion of a Protocol to the Partnership and Cooperation Agreement establishing a partnership between the European Communities and their Member States, of the one part, and the Republic of Moldova, of the other part, on a Framework Agreement between the Europea... | null |
Traian Ungureanu | MEP | PPE | en | en | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | In my capacity as EPP shadow rapporteur on the EU-Republic of Moldova Agreements, I warmly welcome the vote with an overwhelming majority in favour of the conclusion of the Protocol to the EU-Republic of Moldova Partnership and Cooperation Agreement on the participation of the Republic of Moldova in the Union’s program... | null |
Viktor Uspaskich | MEP | ALDE | en | lt | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | The European Union, including the new Member States like Lithuania, is responsible for observing the interests of our eastern neighbours. The strengthening of cooperation between the EU and Moldova and the inclusion of Moldova in Community programmes will help bring this country closer to EU standards and norms. The P... | null |
Damien Abad | MEP | PPE | en | fr | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | Parliament today adopted two legislative reports at first reading: a regulation relating to aspects specific to the European Union and a directive on the rules to be applied by Member States at national level. Member States will be responsible for national legislation to ensure that objective and impartial information... | null |
Sophie Auconie | MEP | PPE | en | fr | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | Directive 2001/83/EC establishes a Community code relating to medicinal products for human use. It lays down rules on the information to be annexed to medicinal products concerning their characteristics and use. Nonetheless, it does not provide a harmonised framework on the contents and the quality of non-promotional ... | null |
Zigmantas Balčytis | MEP | S&D | en | lt | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | I voted for this important resolution which aims to enable patients to be better informed on the medicines they are prescribed. There are considerable problems with the current legal framework and the situation within Europe when it comes to patients’ access to information on prescription-only medicine. The difference... | null |
Sebastian Valentin Bodu | MEP | PPE | en | ro | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | Providing patients with better access to quality information about the treatment being administered to them increases the chances of them understanding the decision directly affecting them. There is therefore a very good intention behind this; however, it must be part of a more comprehensive health education strategy,... | null |
Vito Bonsignore | MEP | PPE | en | it | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | I should like to congratulate the rapporteur, my colleague Mr Fjellner, on his work on this report. I voted in favour as I believe it is essential to guarantee patients access to information on prescription-only medicinal products. Both the European Parliament and patients’ organisations have for some time been asking... | null |
Alain Cadec | MEP | PPE | en | fr | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | In the area of health, access to comprehensive, good quality information guarantees better results, insofar as patients are more likely to follow a treatment that they are able to understand. I join with the rapporteur in emphasising the difficulty in accessing this kind of information in some European countries, due ... | null |
Maria Da Graça Carvalho | MEP | PPE | en | pt | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | The amendments that the European Parliament put forward to a proposal by the Commission relating to information on medicines warranted my vote in favour, as I believe it to be essential for the general public to have easy access to knowledge concerning medicines, in particular through information being made available ... | null |
Françoise Castex | MEP | S&D | en | fr | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | I voted against this text, as we cannot allow pharmaceutical companies and the Commission to turn health into a commodity like any other. The link between the pharmaceutical industry in Europe and pharmacovigilance is yet again at the heart of the debate. We cannot let pharmaceutical firms inform the public as they pl... | null |
Nikolaos Chountis | MEP | GUE/NGL | en | el | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | The European Commission’s initial proposal for a directive on information to the general public on medicinal products subject to medical prescription has thrown the doors open for pharmaceutical companies to advertise their drugs. Today plenary amended the Commission’s initial proposal, which was tailored to the pharm... | null |
Vasilica Viorica Dăncilă | MEP | S&D | en | ro | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | I think that patients must have access to better information about medicinal products subject to medical prescription. This entails providing objective information about the medicines’ characteristics and the diseases for which they are recommended, as well as preventing the provision of unsolicited information or dis... | null |
Christine De Veyrac | MEP | PPE | en | fr | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | Making a distinction between information and advertising concerning medicines is essential for the protection of the public. That is why I voted in favour of Mr Fjellner’s report, which requires that an objective description for patients’ use be included on the packaging of medicines. Furthermore, access to clear and ... | null |
Anne Delvaux | MEP | PPE | en | fr | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | I voted against this report, to which I have always expressed my strong opposition. While I approve of the idea of providing better information to patients, I disapprove of the means used to do so. The pharmaceutical industry’s goal will never be one of philanthropy. Moreover, there is a very fine line between informa... | null |
Edite Estrela | MEP | S&D | en | pt | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | I voted in favour of the report on the proposal for a directive of the European Parliament and of the Council amending, as regards information to the general public on medicinal products subject to medical prescription, Directive 2001/83/EC. This directive sets out a Community code relating to medicinal products for h... | null |
José Manuel Fernandes | MEP | PPE | en | es | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | Directive 2001/83/EC, which sets out a Community code relating to medicinal products for human use, provides for a harmonised framework for the advertising of medicines at a Community level, the application of which continues to be a responsibility of the Member States. This legislation prohibits advertising to the ge... | null |
João Ferreira | MEP | GUE/NGL | en | pt | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | This proposal for a directive amends the earlier directive as regards information to the general public on medicinal products subject to medical prescription. In general terms it concentrates, firstly, on the responsibility of the pharmaceutical companies to inform the public, ensuring that this information is not of ... | null |
Elisabetta Gardini | MEP | PPE | en | it | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | Approval of the new legislation on information on medicinal products represents a further step toward guaranteeing patients clearer and more effective information on the drugs they take and are prescribed. We need a harmonised legal framework at European level that not only maintains the ban on advertising medicinal p... | null |
Giovanni La Via | MEP | PPE | en | it | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | I voted in favour of the proposal for a directive as regards information to the general public on medicinal products for human use subject to medical prescription because I believe that harmonising the laws in this sector is a fundamental means of safeguarding the knowledge of European patients. This is actually a ver... | null |
David Martin | MEP | S&D | en | en | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | I voted for this report, which is part of a package which will amend the current 2001 directive on medicinal products for human use. It specifically focuses on the provision of information to the public on prescription-only medicines. The stated aims of the directive are to allow for better access to information for pa... | null |
Marisa Matias | MEP | GUE/NGL | en | pt | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | This proposal, adopted today by a large majority in Parliament, is a great improvement on the initial proposal presented by the Commission, as it better advocates patients’ rights to information. However, despite the clear improvements in Parliament’s report, I abstained because some of the guarantees that would be ne... | null |
Jean-Luc Mélenchon | MEP | GUE/NGL | en | fr | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | Not all the amendments made by this House to the proposal by the Commission and the Council are along the right lines. They adhere strictly to the principle of a single market in medicinal products and still view products available over the counter as goods like any others; the authors even end up talking of ‘consumer... | null |
Nuno Melo | MEP | PPE | en | pt | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | Access to quality information relating to medicinal products that are subject to medical prescription will contribute to achieving better results in terms of patient health, in that the better informed they are, the more likely they will be to better understand decisions related to their treatment. Therefore, the obje... | null |
Andreas Mölzer | MEP | NI | en | de | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | Elderly people and the chronically ill in particular have a multitude of medicines prescribed to them, which could adversely affect each other – because, of course, one doctor does not know what his colleague has prescribed. Meanwhile ever more products, from aspirin to cold remedies right through to sleeping remedies... | null |
Alfredo Pallone | MEP | PPE | en | it | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | I voted in favour of Mr Fjellner’s report, inasmuch as I believe that the message and guidelines provided are extremely important. European consumers are often lost when faced with medicinal product package leaflets because they find them complicated and they contain information that is often confusing. The very aim o... | null |
Maria do Céu Patrão Neves | MEP | PPE | en | pt | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | I believe the establishment of the distinction between information and advertising that is made with regard to medicines to be fundamental for the protection of citizens. My vote in favour of the Fjellner Report was a result of the clear improvements that were introduced into Directive 2001/83/EC. The large majority t... | null |
Aldo Patriciello | MEP | PPE | en | it | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | I would like to thank Mr Fjellner for his excellent work. I voted in favour because I agree that non-promotional information on medicinal products must be made available to patients and the general public by marketing authorisation holders according to the ‘pull principle’ whereby patients/the public have access to in... | null |
Rovana Plumb | MEP | S&D | en | ro | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | The information supplied to patients should fulfil the following main characteristics: - Reliability: information to patients should be based on the latest scientific knowledge with clear references made to the sources this knowledge comes from; - Independence: it has to be clear who provides and who finances the info... | null |
Paulo Rangel | MEP | PPE | en | pt | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | I voted in favour of this report since I welcome the fact that the compromise changes introduced into the proposal initially presented by the Commission will have contributed decisively to guaranteeing patient access to reliable and independent information on prescription-only medicines that are available on the marke... | null |
Frédérique Ries | MEP | ALDE | en | fr | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | Advertising of prescription-only medicines is banned within the European Union, and remains so. Pharmaceutical companies must comply with clear rules on objectivity in the non-promotional information that they disseminate. These are the two important messages sent this lunchtime with the adoption of the legislative pa... | null |
Raül Romeva i Rueda | MEP | Greens/EFA | en | en | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | We decided we would vote in favour or abstain depending on the result of the third part of Amendment 31, which ensures that pharmaceutical companies can only provide information material to health professionals for their own use, not for patients via healthcare professionals. This was key for the Greens/EFA. As it was ... | null |
Sergio Paolo Francesco Silvestris | MEP | PPE | en | it | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | Our vote in favour of this measure is a consequence of the formal distinction that has been made between information on medicinal products and advertising. We support the greater dissemination of information on medicinal products, if this improves patients’ awareness. We do not, and shall never, agree with any measure... | null |
Bart Staes | MEP | Greens/EFA | en | nl | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | In an age when people search for information themselves, patients must be informed clearly, objectively, reliably and well about the effects of medicinal products. Although advertising of medicinal products is banned in the Union, the Commission has created an opening. Its proposal – which I did not endorse – lacked s... | null |
Marc Tarabella | MEP | S&D | en | fr | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | The Fjellner report on information on medicinal products raises legitimate concerns regarding the possibilities for pharmaceutical companies to advertise to patients. My colleagues in the Committee on the Environment, Public Health and Food Safety have certainly improved the text by refusing to support several kinds o... | null |
Thomas Ulmer | MEP | PPE | en | de | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | I voted in favour of the report because it provides a clear and sustainable improvement to patient information on medicinal products. The advertising of medicinal products continues to be prohibited. The doctor-patient relationship will not be adversely affected by the directive and the authority of the service provid... | null |
Angelika Werthmann | MEP | NI | en | de | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | This directive will introduce for the first time uniform regulations on the provision of certain information to the general public on medicinal products subject to medical prescription. The necessary information is to explain to patients the benefits and risks associated with prescription-only medicinal products to en... | null |
Sophie Auconie | MEP | PPE | en | fr | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | Regulation | null |
Charalampos Angourakis | MEP | GUE/NGL | en | el | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | The Greek Communist Party voted against both proposals for a regulation and the corresponding European Parliament reports, because they shift the responsibility for responsible, reliable and accurate information for patients from government departments to the multinational pharmaceutical companies. Information for pat... | null |
Zigmantas Balčytis | MEP | S&D | en | lt | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | I voted in favour of this report which strives to ensure the key EU objective of ensuring the proper functioning of the internal market for medicinal products for human use and of better protecting the health of EU citizens. The document adopted today will create the conditions to plan a clear framework for informatio... | null |
Anne Delvaux | MEP | PPE | en | fr | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | I voted against this report, to which I have always expressed my strong opposition. While I approve of the idea of providing better information to patients, I disapprove of the means used to do so. The pharmaceutical industry’s goal will never be one of philanthropy. Moreover, there is a very fine line between informa... | null |
Edite Estrela | MEP | S&D | en | pt | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | I voted in favour of the report on the proposal for a regulation of the European Parliament and of the Council on amending, as regards information to the general public on medicinal products for human use subject to medical prescription, Regulation | null |
Diogo Feio | MEP | PPE | en | pt | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | Given how important patient compliance and the correct administration of medicinal products are for successful treatment, it is vital that the public, that is, the patients, have access to good quality, non-advertising information that is true, current and not misleading, in line with the Summary of Product Characteri... | null |
Ian Hudghton | MEP | Greens/EFA | en | en | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | It is important for patients to be better informed about any medications they are taking. It is important too that any information they receive is objective and that the pharmaceutical industry does not blur the line between information and advertising. The Committee on Economic and Monetary Affairs (ECON) has done a g... | null |
Alan Kelly | MEP | S&D | en | en | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | I do not agree with direct-to-consumer advertising in relation to pharmaceutical products. It is important for patients to have access to information on the medicine that they are taking but I feel that this type of advertising would undermine the doctor’s role as gatekeeper and may damage their responsibility to patie... | null |
Giovanni La Via | MEP | PPE | en | it | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | I congratulate Mr Fjellner on his important work as regards information to the general public on medicinal products for human use subject to medical prescription and more particularly on EU procedures for medicinal product authorisation and monitoring. The current EU legal framework on the scientific information provi... | null |
Petru Constantin Luhan | MEP | PPE | en | ro | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | I voted in favour of this report as I am particularly interested in health-related topics, especially concerning equal access for patients to medical care and information. At the moment, the level of information about the medicines available on the market varies hugely in Europe, which I could say is even unfair to pa... | null |
Jean-Luc Mélenchon | MEP | GUE/NGL | en | fr | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | This report consists of a reminder of what the European Medicines Agency should be. One cannot oppose a draft that states obvious facts such as the need to ‘place emphasis on the rights and interests of patients’, the need to oblige companies to publicly list the adverse reactions of their medicines and the need to pu... | null |
Nuno Melo | MEP | PPE | en | pt | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | Access to quality information relating to medicinal products that are subject to medical prescription will contribute to achieving better results in terms of patient health, because the better informed they are, the more likely they will be to better understand decisions related to their treatment. Therefore, the obje... | null |
Louis Michel | MEP | ALDE | en | fr | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | In order to safeguard the rights and interests of patients, the latter should be able to avail themselves of good quality, objective, reliable and non-promotional information on medicines. If we wish to protect health, pharmaceutical leaflets must be as clear and comprehensive as possible, and must satisfy basic quali... | null |
Alexander Mirsky | MEP | S&D | en | lv | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | Mr Fjellner’s report is very timely. The veiled advertising of medicines is unacceptable. Doctors must be able to give their patients recommendations on medicines. Doctors must regulate and prescribe medicines to patients, in order to avoid speculation and competition between drug manufacturers. Pharmaceutical compani... | null |
Andreas Mölzer | MEP | NI | en | de | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | In view of the fact that, in Germany alone, around 25 000 people die each year as a result of adverse reactions and interactions and 3% of accidents can be attributed to prescription-only medicines, it is clear that we must provide patients with better information. For instance, we could take France as an example, whe... | null |
Alfredo Pallone | MEP | PPE | en | it | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | Since it focuses on the patient’s right to information, I fully support the report, which includes some important innovations. The first concerns the Internet: Parliament intends to make consumers aware of the risks of buying drugs online while also pushing for the proposal of ad hoc legislation on this selling method... | null |
Maria do Céu Patrão Neves | MEP | PPE | en | pt | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | The report on the proposed regulation of the European Parliament and of the Council amending Regulation | null |
Rovana Plumb | MEP | S&D | en | ro | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | There are many sources of independent and evidence-based information on treatment options available within the European Union. These resources take into account cultural specificities and contexts for the population, including health determinants. Increased access to quality information will help achieve better health... | null |
Paulo Rangel | MEP | PPE | en | pt | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | I voted in favour of the report on the proposed regulation of the European Parliament and of the Council amending, as regards information to the general public on medicinal products for human use subject to medical prescription, Regulation | null |
Crescenzio Rivellini | MEP | PPE | en | it | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | In today’s sitting, we voted at first reading on the proposal for a regulation of the European Parliament and the Council as regards information on medicinal products (EU procedures for the authorisation and supervision of medicinal products). Parliament and patient organisations have been asking for such a proposal f... | null |
Raül Romeva i Rueda | MEP | Greens/EFA | en | en | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | This report welcomes the proposal by the Commission on information to patients on prescription-only medicines (COM(2008)0662-0663). Parliament and patient organizations have been asking for such a proposal for a long time, in order to enable patients to better informed on the medicines they are prescribed and taking. I... | null |
Christel Schaldemose | MEP | S&D | en | da | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | We, the Danish Social Democrats in the European Parliament (Dan Jørgensen, Christel Schaldemose, Britta Thomsen and Ole Christensen), have abstained from voting on the report on the proposal for a regulation of the European Parliament and of the Council on amending, as regards information to the general public on medi... | null |
Silvia-Adriana Ţicău | MEP | S&D | en | ro | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | I voted in favour of the proposal for a regulation of the European Parliament and of the Council on amending, as regards information to the general public on medicinal products for human use subject to medical prescription, Regulation The report presented by the Commission on 20 December 2007 concerning ‘current prac... | null |
Göran Färm | MEP | S&D | en | sv | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | In view of the fact that, in a former job, I acted as a consultant for one of the interested parties in this matter, I have today abstained from voting on these reports, in other words, A7-0289/2010 and A7-0290/2010. | null |
Sophie Auconie | MEP | PPE | en | fr | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | Every year, in Europe, there is an estimated 9.3 million tonnes of electronic equipment waste. The fact is that this equipment often contains a substantial amount of highly polluting materials. This waste presents a considerable environmental challenge. Reprocessing aside, it would appear vital to restrict, from the o... | null |
Zigmantas Balčytis | MEP | S&D | en | lt | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | I supported this report. Every year, in the EU alone, an estimated 9.3 million tonnes of electrical and electronic equipment (EEE) are sold annually, the biggest share of which are large household appliances and IT and telecommunication equipment. As the market continues to grow and innovation cycles become even short... | null |
Jean-Luc Bennahmias | MEP | ALDE | en | fr | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | The European Parliament has ratified the agreement with the Council under the ordinary legislative procedure by adopting, at first reading, the recast of the directive restricting the use of certain hazardous substances in electrical and electronic equipment. This is good news for European consumers: electrical and el... | null |
Vito Bonsignore | MEP | PPE | en | it | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | I should like to congratulate the rapporteur, Mrs Evans, on her work and the good compromise that she managed to reach amongst our political groups. The text adopted, a recast of the directive currently in force, aims to set more ambitious parameters for the use of electrical and electronic equipment (EEE). It should ... | null |
Edite Estrela | MEP | S&D | en | pt | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | I voted in favour of the report on the proposal for a directive of the European Parliament and of the Council on the restriction of the use of certain hazardous substances in electrical and electronic equipment (recast), as I believe that the agreement reached with the Council meets the objective of contributing to th... | null |
Diogo Feio | MEP | PPE | en | pt | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | According to the Commission, 9.3 million tonnes of electrical and electronic equipment (EEE) are sold every year in the EU alone, most of which comprises large household appliances and IT and telecommunications equipment. As the market continues to grow and innovation cycles become shorter, waste electrical and electr... | null |
José Manuel Fernandes | MEP | PPE | en | pt | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | This recast relating to the restriction of the use of certain hazardous substances in electrical and electronic equipment (RoHS) is necessary, according to the Commission, because of uncertainty with regard to scope, a lack of clarity with regard to legal provisions, and disparities among Member States with regard to ... | null |
João Ferreira | MEP | GUE/NGL | en | pt | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | The amount of sales of electrical and electronic equipment in the EU and the inevitable increase in waste from this equipment means that there is a need to replace certain hazardous substances in them, so as to minimise their impact on the environment and ensure the protection of consumers and public health. We realis... | null |
Robert Goebbels | MEP | S&D | en | fr | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | I abstained on the Evans report on the restriction of the use of certain hazardous substances in electrical and electronic equipment because I find Parliament’s approach strange. On the one hand, the report relentlessly opposes, without any scientific proof, nanoparticles, which, because they are small, must necessari... | null |
Matthias Groote | MEP | S&D | en | de | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | I voted in favour of the report on the restriction of the use of certain hazardous substances in electrical and electronic equipment (RoHS), because the extension of the area of application to cover all electronic equipment represents a definite improvement. However, I find the fact that there are so many exceptions p... | null |
Françoise Grossetête | MEP | PPE | en | fr | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | Waste electrical and electronic equipment is increasing all the time, and it brings together several hazardous substances. These substances may be discharged into the environment and harm human health if they are not treated properly. This directive will enable numerous companies to make even more progress in designin... | null |
Małgorzata Handzlik | MEP | PPE | en | pl | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | Poland is one of the largest producers of television, radio and domestic electrical appliances in Europe. It is also a country in which sales of this type of appliance are rising year by year. The development of technology and the growth in demand for goods of this type are also causing an increase in the quantities o... | null |
Jutta Haug | MEP | S&D | en | en | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | Though not very ambitious, the first reading compromise improves the current legislation – I therefore voted in favour. Besides the new methodology for substance restrictions, one key improvement is the open scope: all electric and electronic equipment, including equipment for the generation of electric currents, will ... | null |
Ian Hudghton | MEP | Greens/EFA | en | en | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | The compromise negotiated by my colleague Jill Evans marks progress in this area of law. The legal certainty it provides will lead to improvements in environmental protection and I accordingly voted in favour of the report. | null |
Jarosław Kalinowski | MEP | PPE | en | pl | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | The constantly rising production of television, radio and domestic electrical appliances is the result of the development of modern technologies and the increase in demand for this type of product. As consumers, we expect functionality and ergonomics from these appliances, but above all we should require that differen... | null |
Alan Kelly | MEP | S&D | en | en | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | The current RoHS restricts the use of six hazardous materials that were once contained in certain electrical and electronic equipment. It is being recast in order to simplify it and to make it easier for producers to tell which substances are banned, so as to avoid any unnecessary mix-ups that could be dangerous to the... | null |
Giovanni La Via | MEP | PPE | en | it | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | The European Union needed a detailed set of rules on the use of certain substances considered hazardous in electrical and electronic equipment. This requirement is made clear from Commission data, which shows that, every year, in the EU alone, an estimated 9.3 million tonnes of electrical and electronic equipment (EEE... | null |
David Martin | MEP | S&D | en | en | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | I voted for this report on the restriction of the use of certain hazardous substances in electrical and electronic equipment. The current Restriction of Hazardous Substances Directive restricts the use of six hazardous materials in the manufacturing of certain electronic and electrical equipment. It is intended to avoi... | null |
Marisa Matias | MEP | GUE/NGL | en | pt | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | The use of hazardous substances in electrical and electronic equipment is a major problem for public health, for the environment and for waste management. These risks are even greater in recycling and recovery operations under poor conditions in developing countries, especially in the case of illegal exporting for dis... | null |
Nuno Melo | MEP | PPE | en | pt | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | The increased use of electrical and electronic equipment, combined with their considerable technological development, has led to an ever shortening life cycle. This, in turn, has led to serious problems with regard to the use of dangerous substances in this equipment, as well as difficulties in the management of the e... | null |
Alexander Mirsky | MEP | S&D | en | lv | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | I fully support Mrs Evans’s report. However, I should like to add that this issue should be paid more attention. The use of lead, magnesium, mercury and rare-earth metals in electronics and industrial technology is unavoidable. Our task is to compel manufacturers to move over to less harmful materials. Where that is n... | null |
Andreas Mölzer | MEP | NI | en | de | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | The directive on the restriction of the use of certain hazardous substances in electrical and electronic equipment (RoHS) governs the use of hazardous substances in devices and components. It is also an important instrument for setting a European, as well as global, standard for manufacturers. The extension of the sco... | null |
Franz Obermayr | MEP | NI | en | de | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | There has certainly been a rapid growth in the market for electrical equipment, in particular in the areas of IT and telecommunications. This and the ever shorter innovation cycles are also resulting in ever increasing amounts of electrical waste. The recast of the RoHS Directive is aimed at preventing the use of haza... | null |
Alfredo Pallone | MEP | PPE | en | it | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | I voted in favour of the report for a variety of reasons. I agree that fixed installations and photovoltaic panels should be excluded from the scope of the directive. I was also pleased at the adoption of a methodology for reviewing the hazardous substances contained in Annex IV, as it means that the list of substance... | null |
Maria do Céu Patrão Neves | MEP | PPE | en | pt | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | My vote in favour of the report on the proposal for a directive of the European Parliament and of the Council on the restriction of the use of certain hazardous substances in electrical and electronic equipment (recast) was due to the improvements introduced by mutual agreement with the Council, which should contribut... | null |
Aldo Patriciello | MEP | PPE | en | it | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | I would like to thank Mrs Evans for her excellent work. I voted in favour because I agree that the RoHS recast needs to be put into the context of the EU’s international obligations to reduce total releases of dioxins and furans, with the goal of their continuing minimisation and, where feasible, ultimate elimination.... | null |
Rovana Plumb | MEP | S&D | en | ro | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | In the EU alone, an estimated 9.3 million tonnes of electrical and electronic equipment (EEE) are sold annually, the biggest share of which are large household appliances and IT and telecommunication equipment. As the market continues to grow and innovation cycles become increasingly shorter, the replacement of equipm... | null |
Paulo Rangel | MEP | PPE | en | pt | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | According to the Commission, it is advisable to reformulate the current directive relating to the restriction of the use of certain hazardous substances in electrical and electronic equipment, adopted in 2003, on the grounds of clarity and legal certainty. This recast naturally requires the expansion of the directive’... | null |
Frédérique Ries | MEP | ALDE | en | fr | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | Nearly eight years ago, the European Parliament adopted a directive on the restriction of hazardous substances (the RoHS Directive), and thereby responded to a strong demand by consumers for safe and non-harmful everyday consumer products. This safety approach was implemented mainly through a ban on the use of lead, m... | null |
Crescenzio Rivellini | MEP | PPE | en | it | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | At today’s sitting, I voted in favour of the revision of the directive on the use of hazardous substances in electric or electronic equipment. Partly as a result of new scientific knowledge on the subject, the text – a recast of the 2003 directive – seeks to introduce restrictions on the use of materials such as cadmi... | null |
Raül Romeva i Rueda | MEP | Greens/EFA | en | en | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | According to the Commission, every year, in the EU alone, an estimated 9.3 million tonnes of electrical and electronic equipment (EEE) are sold annually, the biggest share of which are large household appliances and IT and telecommunication equipment. As the market continues to grow and innovation cycles become even sh... | null |
Daciana Octavia Sârbu | MEP | S&D | en | en | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | Electronic equipment produces the fastest growing waste stream in Europe, and reducing the carcinogenic and toxic substances from this waste stream must be a top priority. The open scope of the legislation, as recommended by the Environment Committee, is a much better approach than that proposed by the Commission. A de... | null |
Bart Staes | MEP | Greens/EFA | en | nl | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | I have endorsed the report on the restriction of the use of certain hazardous substances in electrical and electronic equipment. This report is a step in the right direction. It extends the category of equipment to, inter alia, medical apparatus. In addition to heavy metals such as mercury and lead, a number of bromin... | null |
Marianne Thyssen | MEP | PPE | en | nl | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | It has become impossible to imagine our daily life without electrical and electronic equipment. The European Restriction of Hazardous Substances (RoHS) system that regulates the use of hazardous substances in this electronic equipment has in fact become a universal system that is used in no less than 28 non-EU countri... | null |
Thomas Ulmer | MEP | PPE | en | de | 2010-11-24T00:00:00 | 2010 | Explanations of voteVideo of the speechesPV | This is a good report, which takes most of the concerns of the industry and environmental protection concerns into account in a balanced manner. Although it will surely not be possible to achieve complete satisfaction in relation to such a complex matter, this provides a very close approximation. | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.